Research

Hormonal

Subcutaneous semaglutide (starting 0.25 mg, titrated to 1 mg weekly) significantly reduces body weight and HbA1c in patients with type 2 diabetes, with maximal efficacy observed when combined with lifestyle modifications (diet and exercise).

If you have Type 2 Diabetes, semaglutide (Ozempic) is an effective tool for losing weight and lowering blood sugar. To get the best results, take it as prescribed (starting low and building up) and combine it with a healthy diet and regular exercise. Be aware that stomach issues like nausea are common reasons people stop taking it, so talk to your doctor about managing these side effects to stay on the medication.

ModerateSupportsMEDIUM confidence
Among patients who adhered to the treatment regimen, maintained a healthy diet, and exercised regularly, significant reductions were observed in both HbA1c (from 8.2±1.54% to 6.9±1.44%; p=0.001) and weight (from 97 kg to 89.2 kg; p<0.001).
Mahmoud A. Alzahrani et al. · Cureus · 2025

Why this rating

Retrospective cohort study in a single primary care setting; lacks randomization and control group, but has a reasonable sample size (N=238) and statistical significance.

Source

Effects of Semaglutide on Glycemic Control and Body Weight in Patients With Type 2 Diabetes: A Retrospective Cohort Study in a Primary Care Setting

Mahmoud A. Alzahrani et al. · Cureus · 2025

DOI 10.7759/cureus.82123

cohort · n=238Cited 4×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →